Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.

BACKGROUND & AIMS In patients with Barrett's esophagus (BE), radiofrequency ablation (RFA) safely and effectively eradicates dysplasia and intestinal metaplasia. We aimed to determine the efficacy and durability of RFA for patients with dysplastic and nondysplastic BE. METHODS We performed a systematic review and meta-analysis of studies identified in PubMed and EMBASE that reported the proportion of patients treated with RFA who had complete eradication of dysplasia (CE-D) and intestinal metaplasia (CE-IM), and the proportion of patients with recurrent IM after successful treatment. Pooled estimates of CE-D, CE-IM, IM recurrence, and adverse events were calculated. RESULTS We identified 18 studies of 3802 patients reporting efficacy and 6 studies of 540 patients reporting durability. Ten were prospective cohort studies, 9 were retrospective cohort studies, and 1 was a randomized trial. CE-IM was achieved in 78% of patients (95% confidence interval [CI], 70%-86%) and CE-D was achieved in 91% (95% CI, 87%-95%). After eradication, IM recurred in 13% (95% CI, 9%-18%). Progression to cancer occurred in 0.2% of patients during treatment and in 0.7% of those after CE-IM. Esophageal stricture was the most common adverse event and was reported in 5% of patients (95% CI, 3%-7%). Confidence in most summary estimates was limited by a high degree of heterogeneity, which did not appear to be caused by single outlier studies. CONCLUSIONS Treatment of BE with RFA results in CE-D and CE-IM in a high proportion of patients, with few recurrences of IM after treatment and a low rate of adverse events. Despite the large amount of study heterogeneity, these data provide additional information for patients and providers to make informed treatment decisions.

[1]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[2]  Hiroshi Mashimo,et al.  Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. , 2011, Gastroenterology.

[3]  J. Akiyama,et al.  Effective Intra-Esophageal Acid Control Is Associated with Improved Radiofrequency Ablation Outcomes in Barrett’s Esophagus , 2012, Digestive Diseases and Sciences.

[4]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[5]  R. K. Pearson.  Radiofrequency Ablation in Barrett's Esophagus with Dysplasia , 2009 .

[6]  Prateek Sharma,et al.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.

[7]  J. Pandolfino,et al.  Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. , 2012, Gastroenterology.

[8]  K. Batts,et al.  Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. , 2004, Gastrointestinal endoscopy.

[9]  K. Behrns,et al.  Incidence of Adenocarcinoma among Patients with Barrett's Esophagus , 2012 .

[10]  E. Kuipers,et al.  Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study , 2011, The American Journal of Gastroenterology.

[11]  Ananya Das,et al.  Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia , 2009, The American Journal of Gastroenterology.

[12]  Paul Fockens,et al.  Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[14]  Kenneth K Wang,et al.  Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  Kenneth K Wang,et al.  Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. , 2009, Gastrointestinal endoscopy.

[16]  Kenneth J. Chang,et al.  Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.

[17]  P. Fockens,et al.  Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm. , 2011, Gastrointestinal endoscopy.

[18]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[19]  Richard S. Kwon,et al.  Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus. , 2011, Gastrointestinal endoscopy.

[20]  P. Mavrelis,et al.  Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry , 2010, Endoscopy.

[21]  J. Tukey,et al.  Transformations Related to the Angular and the Square Root , 1950 .

[22]  Byron C. Wallace,et al.  Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data , 2009, BMC medical research methodology.

[23]  P. Fockens,et al.  Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. , 2008, Gastrointestinal endoscopy.

[24]  A. Rastogi,et al.  Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review , 2009, The American Journal of Gastroenterology.

[25]  B. Heniford,et al.  Radiofrequency ablation offers a Reliable Surgical Modality for the Treatment of Barrett's Esophagus with a Minimal Learning Curve , 2012, The American surgeon.

[26]  N. Shaheen,et al.  Intestinal Metaplasia Recurs Infrequently in Patients Successfully Treated for Barrett's Esophagus With Radiofrequency Ablation , 2013, The American Journal of Gastroenterology.

[27]  B. Esterni,et al.  Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. , 2012, Clinics and research in hepatology and gastroenterology.

[28]  V. Velanovich.  Endoscopic endoluminal radiofrequency ablation of Barrett’s esophagus: initial results and lessons learned , 2009, Surgical Endoscopy.

[29]  N. Soehendra,et al.  Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial , 2011, Gut.

[30]  J. de Caestecker,et al.  Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium , 2002, Gut.

[31]  N. Shaheen,et al.  Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  Kenneth J. Chang,et al.  Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial* , 2010, Endoscopy.

[33]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[34]  B. Overholt,et al.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.

[35]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[36]  Bergein F Overholt,et al.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. , 2007, Gastrointestinal endoscopy.

[37]  R. Sampliner,et al.  Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.